Pfizer reported higher quarterly profits Tuesday as it lifted its full-year forecast for coronavirus vaccine sales and predicted COVID-19 would yield billions more in revenues for the forseeable future.
Nov 1, 2022
0
5
Families who get expensive health insurance through employers could see a price break if they sign up instead for coverage through the Affordable Care Act marketplace this fall.
Oct 11, 2022
0
4
Smoking isn't only costly in terms of health risks, it also cost the U.S. economy $891 billion in 2020.
Sep 29, 2022
0
17
One of AstraZeneca Plc's top-selling drugs Farxiga, a diabetes treatment, is beneficial to a wider pool of patients than previously indicated, a study shows, bolstering the product's blockbuster potential.
Aug 29, 2022
0
5
Research by GPH's Jonathan Purtle says that earmarking state taxes on recreational sales is an underused strategy for financing mobile psychiatric crisis units, the National Suicide Prevention Lifeline, and more.
Apr 21, 2022
0
12
German vaccine-maker BioNTech on Wednesday reported a multi-billion-euro windfall in 2021 from sales of its anti-coronavirus jab, developed together with US pharmaceutical giant Pfizer.
Mar 30, 2022
0
8
Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.
Feb 8, 2022
0
6
More than 90% of federal workers received at least one dose of a COVID-19 vaccine by Monday's deadline set by President Joe Biden.
Nov 22, 2021
1
1
Pfizer again boosted its 2021 profit and revenue outlook on Tuesday, bolstered by the latest surge in COVID-19 vaccinations, including regulatory approvals for boosters and shots for younger children.
Nov 2, 2021
0
2
Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Sep 30, 2021
0
1
